MedTrace Logo

CGM to Aid Transition From Inpatient to Outpatient

NCT03155594 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-05-16

No results posted yet for this study

Summary

A pilot study using the FreeStyle Libre to assess its potential benefits in patients with diabetes starting when they are inpatients and continuing during the transition of care to the outpatient setting to see if diabetes care can be improved after discharge.

This study is designed to address the following questions:

1. How do the glucose readings from FreeStyle Libre Pro compare to our inpatient glucometer system? Is the system is accurate enough to use for clinical decision making?
2. How often does the additional continuous glucose data change inpatient care?
3. Does this technology work with inpatient nursing workflow?
4. Does leaving the patch on at discharge and reading in the office improve transition of care?
5. Does reading the patch after discharge in the office improve follow-up care?

Conditions

  • Diabete Mellitus

Interventions

DEVICE

Freestyle Libre

Continuous glucose monitoring patch

Sponsors & Collaborators

  • Methodist Medical Center of Illinois

    lead OTHER

Principal Investigators

  • David E. Trachtenbarg, MD · Methodist Medical Center of Illinois

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-09
Primary Completion
2017-07-15
Completion
2017-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155594 on ClinicalTrials.gov